-
Categories
-
Pharmaceutical Intermediates
-
Active Pharmaceutical Ingredients
-
Food Additives
- Industrial Coatings
- Agrochemicals
- Dyes and Pigments
- Surfactant
- Flavors and Fragrances
- Chemical Reagents
- Catalyst and Auxiliary
- Natural Products
- Inorganic Chemistry
-
Organic Chemistry
-
Biochemical Engineering
- Analytical Chemistry
-
Cosmetic Ingredient
- Water Treatment Chemical
-
Pharmaceutical Intermediates
Promotion
ECHEMI Mall
Wholesale
Weekly Price
Exhibition
News
-
Trade Service
On March 22, the official website of the State Food and Drug Administration showed that Chengdu Better Pharmaceutical's Ampicillin Sodium for injection successfully passed the evaluation, and it was the first in China; in addition, the company recently imitated the 4 types of dabigatran etexilate capsules.
Will win $1.
Source: official website of the State Food and Drug Administration
Dabigatran etexilate belongs to the β-alanine thrombin inhibitor, which is converted into dabigatran with direct anticoagulant activity in the body after oral absorption through the gastrointestinal tract.
The original research product was approved to enter the domestic market as early as February 2013.
Sales of Dabigatran Etexilate Capsules in Entity Pharmacies in Chinese Cities (Unit: RMB million)
Source: Mi Nei.
In recent years, the sales of dabigatran etexilate in physical pharmacies in Chinese cities have increased year by year.
In addition to the original manufacturers, there are currently two domestic companies, Zhengda Tianqing and Hausen, that have approvals for the production of dabigatran etexilate capsules.
Chengdu Better Pharmaceutical Co.
Source: Meinenet MED2.
According to data from Minai.
The first review of ampicillin sodium for injection
Ampicillin sodium is a broad-spectrum semi-synthetic penicillin, suitable for respiratory infections, gastrointestinal infections, urinary tract infections, soft tissue infections, endocarditis, meningitis, sepsis, etc.
At present, there are more than 30 domestic companies with approvals for the production of ampicillin sodium for injection.
Consistency Evaluation and Application Status of Ampicillin Sodium for Injection
Source: Mi Nei Net Consistency Evaluation Database
Two companies, Chengdu Better Pharmaceuticals and Harbin Pharmaceutical Group Pharmaceutical General Factory, submitted supplementary applications for the consistency evaluation of ampicillin sodium for injection.
Source: Minei.
Note: China's urban entity pharmacy terminal competition pattern database is an enlarged version of the urban entity pharmacy database that covers 293 prefectures and cities across the country (excluding county and rural entity pharmacies), and continuously monitors all categories.
